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Measure the Impact
Because psoriasis impacts 
patient quality of life (QoL), 
Grozdev and colleagues 
evaluated the Short Form–12 
(SF-12), which contains 
12 questions drawn from 
the previously validated 
generic Short Form–36 QoL 
instrument, for assessment 
of the mental and physical 
component scores (MCS and 
PCS, respectively) of psoriasis 
patients. This study confirmed 
a negative impact of psoriasis 
on QoL in patients that was 
similar to that observed in 
major chronic diseases, and it 
verified a relationship between 
psoriasis severity and MCS and 
PCS. The results support the 
use of the SF-12 in assessing 
QoL in psoriasis patients in 
conjunction with disease-
specific tools. See page 1111
Tools of the Trade
Currently, effective treatments 
for the cutaneous symptoms 
of the chronic systemic 
autoimmune disease 
dermatomyositis (DM) are 
limited. Thus, development of 
optimal validated instruments 
to quantify organ-specific 
disease is critical to allow 
evaluation of medication 
efficacy. In a study of 14 
patients with DM, Goreshi 
and colleagues found that 
the Cutaneous Disease and 
Activity Severity Index (CDASI) 
was a better clinical tool to 
assess skin severity than the 
Cutaneous Assessment Tool–
Binary Method because the 
CDASI had higher inter- and 
intrarater reliability and the 
highest level of responsiveness 
among the three instruments 
evaluated. See page 1117
Reduced Patches
Chronic UVR exposure results in the 
accum ulation of p53 patches, which 
are clonal keratino cyte outgrowths 
with mutant p53. These patches may 
progress to actinic keratosis (AK) and 
eventually to non melanoma skin can-
cer (NMSC). Cozzi and colleagues 
demonstrated that treatment of UVB-
irradiated mouse skin with the topical 
antineoplastic drug ingenol mebutate not only resulted in a 70% reduction in the 
number of skin lesions but also caused a significant reduction in the number of mutant 
p53 patches. These results suggest that this drug effectively removes mutant p53–
expressing keratino cytes and may be a useful field-directed treatment for chronically 
UVB-damaged skin to prevent development of AK and NMSC. See page 1263
Two Pathways Intersect
Mutations in the endoplasmic reticulum 
Ca2+ ATPase SERCA2b result in the character-
istic defects in epidermal cell adhesion and 
differentiation observed in Darier’s disease 
(DD). Because sphingolipid signaling is 
involved in keratinocyte Ca2+ regulation, 
Celli and colleagues investigated the rela-
tionship between these two pathways. 
Indeed, sphingolipid and Ca2+ signaling 
intersect to control SERCA2–ER Ca2+ seques-
tration. Inhibition of sphingosine phosphate 
lyase rescued ER Ca2+ depletion-induced defects in keratinocyte differentiation and 
adhesion and normalized ER Ca2+ stores that resulted from SERCA2 inhibition. These 
results suggest that modulating the sphingolipid pathway may mitigate the defective 
cell adhesion that occurs in DD. See page 1188
Introducing Inflammation
Although IFN-γ-producing T helper type 
1 (Th1) cells were originally thought to be 
involved in psoriasis, IFN-γ also induces IL-23 
and IL-1 production to induce Th17 cells, 
which are crucial players in the inflammatory 
cascade involved in psoriatic lesions. 
Johnson-Huang et al. found that a single intra-
dermal injection of IFN-γ to nonlesional skin 
in psoriasis patients invoked an inflammatory 
environment complete with chemokines, 
inflammatory cytokines, an influx of T cells 
and inflammatory dendritic cells, and an increase in IFN-γ response genes. This 
observed inflammatory response mirrors many of the changes that occur in psoriatic 
lesions and supports a role for IFN-γ in mediating skin inflammation. See page 1177
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